AccessHope Secures $33 Million in Series B Funding to Expand Access to Leading Cancer Expertise
DUARTE, Calif., April 22, 2024 /PRNewswire/ -- AccessHope, LLC, a company changing the way leading-edge cancer expertise is delivered, today announced that it has raised $33 million in a Series B round of funding from City of Hope, one of the largest cancer research and treatment organizations in the United States. AccessHope's next phase of growth as a stand-alone company will include product and technology development, oncology network expansion and entering new markets, such as health plans, Medicare and government organizations.
- To lead its transformation into a commercial business, AccessHope appointed seasoned healthcare, payer and investment veteran Bradley Kreick as its new CEO.
- Kreick, who has served on the AccessHope board since 2023, brings 30 years of experience leading companies through periods of significant growth.
- "AccessHope was founded with the mission of bringing cutting-edge cancer care knowledge to the places and people who need it most.
- Through these collaborations, AccessHope members now have access to expertise from more than 350 of the world's top oncologists, covering all cancer types and stages.